The Evaluation of Therapeutic Efficacy and Safety Profile of Simvastatin Prodrug Micelles in a Closed Fracture Mouse Model

Yijia Zhang, Zhenshan Jia, Hongjiang Yuan, Anand Dusad, Ke Ren, Xin Wei, Edward V. Fehringer, P. Edward Purdue, Aaron Daluiski, Steven R. Goldring, Dong Wang

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Purpose: To evaluate the therapeutic efficiency of a micellar prodrug formulation of simvastatin (SIM/SIM-mPEG) and explore its safety in a closed femoral fracture mouse model. Methods: The amphiphilic macromolecular prodrug of simvastatin (SIM-mPEG) was synthesized and formulated together with free simvastatin into micelles. It was also labeled with a near infrared dye for in vivo imaging purpose. A closed femoral fracture mouse model was established using a three-points bending device. The mice with established closed femoral fractures were treated with SIM/SIM-mPEG micelles, using free simvastatin and saline as controls. The therapeutic efficacy of the micelles was evaluated using a high-resolution micro-CT. Serum biochemistry and histology analyses were performed to explore the potential toxicity of the micelle formulation. Results: Near Infrared Fluorescence (NIRF) imaging confirmed the passive targeting of SIM/SIM-mPEG micelles to the bone lesion of the mice with closed femoral fractures. The micelle was found to promote fracture healing with an excellent safety profile. In addition, the accelerated healing of the femoral fracture also helped to prevent disuse-associated ipsilateral tibia bone loss. Conclusion: SIM/SIM-mPEG micelles were found to be an effective and safe treatment for closed femoral fracture repair in mice. The evidence obtained in this study suggests that it may have the potential to be translated into a novel therapy for clinical management of skeletal fractures and non-union.

Original languageEnglish (US)
Pages (from-to)1-13
Number of pages13
JournalPharmaceutical Research
DOIs
StateAccepted/In press - May 10 2016

Fingerprint

Closed Fractures
Simvastatin
Prodrugs
Micelles
Femoral Fractures
Safety
Therapeutics
Bone
Bone and Bones
Fracture Healing
Infrared radiation
Imaging techniques
Optical Imaging
Biochemistry
Histology
Tibia
Coloring Agents
Toxicity
Repair
Fluorescence

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Organic Chemistry
  • Molecular Medicine
  • Pharmacology (medical)
  • Biotechnology
  • Pharmacology

Cite this

The Evaluation of Therapeutic Efficacy and Safety Profile of Simvastatin Prodrug Micelles in a Closed Fracture Mouse Model. / Zhang, Yijia; Jia, Zhenshan; Yuan, Hongjiang; Dusad, Anand; Ren, Ke; Wei, Xin; Fehringer, Edward V.; Purdue, P. Edward; Daluiski, Aaron; Goldring, Steven R.; Wang, Dong.

In: Pharmaceutical Research, 10.05.2016, p. 1-13.

Research output: Contribution to journalArticle

Zhang, Yijia ; Jia, Zhenshan ; Yuan, Hongjiang ; Dusad, Anand ; Ren, Ke ; Wei, Xin ; Fehringer, Edward V. ; Purdue, P. Edward ; Daluiski, Aaron ; Goldring, Steven R. ; Wang, Dong. / The Evaluation of Therapeutic Efficacy and Safety Profile of Simvastatin Prodrug Micelles in a Closed Fracture Mouse Model. In: Pharmaceutical Research. 2016 ; pp. 1-13.
@article{dbe1489b781746b4a42901ed61ddc2bc,
title = "The Evaluation of Therapeutic Efficacy and Safety Profile of Simvastatin Prodrug Micelles in a Closed Fracture Mouse Model",
abstract = "Purpose: To evaluate the therapeutic efficiency of a micellar prodrug formulation of simvastatin (SIM/SIM-mPEG) and explore its safety in a closed femoral fracture mouse model. Methods: The amphiphilic macromolecular prodrug of simvastatin (SIM-mPEG) was synthesized and formulated together with free simvastatin into micelles. It was also labeled with a near infrared dye for in vivo imaging purpose. A closed femoral fracture mouse model was established using a three-points bending device. The mice with established closed femoral fractures were treated with SIM/SIM-mPEG micelles, using free simvastatin and saline as controls. The therapeutic efficacy of the micelles was evaluated using a high-resolution micro-CT. Serum biochemistry and histology analyses were performed to explore the potential toxicity of the micelle formulation. Results: Near Infrared Fluorescence (NIRF) imaging confirmed the passive targeting of SIM/SIM-mPEG micelles to the bone lesion of the mice with closed femoral fractures. The micelle was found to promote fracture healing with an excellent safety profile. In addition, the accelerated healing of the femoral fracture also helped to prevent disuse-associated ipsilateral tibia bone loss. Conclusion: SIM/SIM-mPEG micelles were found to be an effective and safe treatment for closed femoral fracture repair in mice. The evidence obtained in this study suggests that it may have the potential to be translated into a novel therapy for clinical management of skeletal fractures and non-union.",
author = "Yijia Zhang and Zhenshan Jia and Hongjiang Yuan and Anand Dusad and Ke Ren and Xin Wei and Fehringer, {Edward V.} and Purdue, {P. Edward} and Aaron Daluiski and Goldring, {Steven R.} and Dong Wang",
year = "2016",
month = "5",
day = "10",
doi = "10.1007/s11095-016-1932-2",
language = "English (US)",
pages = "1--13",
journal = "Pharmaceutical Research",
issn = "0724-8741",
publisher = "Springer New York",

}

TY - JOUR

T1 - The Evaluation of Therapeutic Efficacy and Safety Profile of Simvastatin Prodrug Micelles in a Closed Fracture Mouse Model

AU - Zhang, Yijia

AU - Jia, Zhenshan

AU - Yuan, Hongjiang

AU - Dusad, Anand

AU - Ren, Ke

AU - Wei, Xin

AU - Fehringer, Edward V.

AU - Purdue, P. Edward

AU - Daluiski, Aaron

AU - Goldring, Steven R.

AU - Wang, Dong

PY - 2016/5/10

Y1 - 2016/5/10

N2 - Purpose: To evaluate the therapeutic efficiency of a micellar prodrug formulation of simvastatin (SIM/SIM-mPEG) and explore its safety in a closed femoral fracture mouse model. Methods: The amphiphilic macromolecular prodrug of simvastatin (SIM-mPEG) was synthesized and formulated together with free simvastatin into micelles. It was also labeled with a near infrared dye for in vivo imaging purpose. A closed femoral fracture mouse model was established using a three-points bending device. The mice with established closed femoral fractures were treated with SIM/SIM-mPEG micelles, using free simvastatin and saline as controls. The therapeutic efficacy of the micelles was evaluated using a high-resolution micro-CT. Serum biochemistry and histology analyses were performed to explore the potential toxicity of the micelle formulation. Results: Near Infrared Fluorescence (NIRF) imaging confirmed the passive targeting of SIM/SIM-mPEG micelles to the bone lesion of the mice with closed femoral fractures. The micelle was found to promote fracture healing with an excellent safety profile. In addition, the accelerated healing of the femoral fracture also helped to prevent disuse-associated ipsilateral tibia bone loss. Conclusion: SIM/SIM-mPEG micelles were found to be an effective and safe treatment for closed femoral fracture repair in mice. The evidence obtained in this study suggests that it may have the potential to be translated into a novel therapy for clinical management of skeletal fractures and non-union.

AB - Purpose: To evaluate the therapeutic efficiency of a micellar prodrug formulation of simvastatin (SIM/SIM-mPEG) and explore its safety in a closed femoral fracture mouse model. Methods: The amphiphilic macromolecular prodrug of simvastatin (SIM-mPEG) was synthesized and formulated together with free simvastatin into micelles. It was also labeled with a near infrared dye for in vivo imaging purpose. A closed femoral fracture mouse model was established using a three-points bending device. The mice with established closed femoral fractures were treated with SIM/SIM-mPEG micelles, using free simvastatin and saline as controls. The therapeutic efficacy of the micelles was evaluated using a high-resolution micro-CT. Serum biochemistry and histology analyses were performed to explore the potential toxicity of the micelle formulation. Results: Near Infrared Fluorescence (NIRF) imaging confirmed the passive targeting of SIM/SIM-mPEG micelles to the bone lesion of the mice with closed femoral fractures. The micelle was found to promote fracture healing with an excellent safety profile. In addition, the accelerated healing of the femoral fracture also helped to prevent disuse-associated ipsilateral tibia bone loss. Conclusion: SIM/SIM-mPEG micelles were found to be an effective and safe treatment for closed femoral fracture repair in mice. The evidence obtained in this study suggests that it may have the potential to be translated into a novel therapy for clinical management of skeletal fractures and non-union.

UR - http://www.scopus.com/inward/record.url?scp=84966628809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966628809&partnerID=8YFLogxK

U2 - 10.1007/s11095-016-1932-2

DO - 10.1007/s11095-016-1932-2

M3 - Article

SP - 1

EP - 13

JO - Pharmaceutical Research

JF - Pharmaceutical Research

SN - 0724-8741

ER -